Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1980 Apr;4:128–132.

The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.

H M Warenius, L S Freedman, N M Bleehen
PMCID: PMC2149238  PMID: 6932916

Abstract

The HT29R human colon adenocarcinoma cell line has been used to investigate the problem of inter-tumour variability in the xenograft system and how this may affect the planning of chemotherapy experiments. Subcutaneous inoculation of 10(6) in vitro cells into immuno-suppressed mice yielded an 80% take rate of moderately poorly differentiated, mucin-secreting tumours with a mean doubling time of 6 days. Statistical estimates from experiments with this system demonstrated that whereas a delay of one doubling time in treated compared with control groups could be detected with relatively small animal numbers, 3 to 4 times as many animals were needed to detect a delay of half a doubling time. The use of 2 tumours per animal yielded the same results as one tumour per animal but reduced the number of animals needed to achieve the same degree of statistical significance.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castro J. E. Human tumours grown in mice. Nat New Biol. 1972 Sep 20;239(90):83–84. doi: 10.1038/newbio239083a0. [DOI] [PubMed] [Google Scholar]
  2. Houghton J. A., Taylor D. M. Growth characteristics of human colorectal tumours during serial passage in immune-deprived mice. Br J Cancer. 1978 Feb;37(2):213–223. doi: 10.1038/bjc.1978.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Houghton J. A., Taylor D. M. Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice. Br J Cancer. 1978 Feb;37(2):199–212. doi: 10.1038/bjc.1978.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kopper L., Steel G. G. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res. 1975 Oct;35(10):2704–2713. [PubMed] [Google Scholar]
  5. Povlsen C. O., Rygaard J. Heterotransplantation of human adenocarcinomas of the colon and rectum to the mouse mutant Nude. A study of nine consecutive transplantations. Acta Pathol Microbiol Scand A. 1971;79(2):159–169. doi: 10.1111/j.1699-0463.1971.tb03324.x. [DOI] [PubMed] [Google Scholar]
  6. Shimosato Y., Kameya T., Nagai K., Hirohashi S., Koide T., Hayashi H., Nomura T. Transplantation of human tumors in nude mice. J Natl Cancer Inst. 1976 Jun;56(6):1251–1260. doi: 10.1093/jnci/56.6.1251. [DOI] [PubMed] [Google Scholar]
  7. Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. von Kleist S., Chany E., Burtin P., King M., Fogh J. Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J Natl Cancer Inst. 1975 Sep;55(3):555–560. doi: 10.1093/jnci/55.3.555. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES